Fecal Microbiome Transplant Trial
Phase 2
56
about 2.2 years
18+
1 site in CA
What this study is about
This trial is testing whether fecal microbiome transplantation can help remodel the gut bacteria in people with lymphoma that has returned after treatment or not responded to treatment, especially those who have taken high-risk antibiotics. Fecal microbiome transplantation involves transplanting healthy gut bacteria from donors into patients to restore a balanced and protective microbiome. This may improve outcomes for these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Axicabtagene Ciloleucel
- 2.Take Chemotherapy
- 3.Take Placebo Administration
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
axicabtagene ciloleucel
Secondary: Incidence and severity of Cytokine Release Syndrome, Incidence of adverse events, Overall response rate, Rate of overall survival
diagnostic, therapy
Oncology